Schizophrenia Spectrum and Other Psychotic Disorders Clinical Trial
Official title:
Effect of Acceptance and Commitment Therapy-based Lifestyle Counselling Programme for People With Early Psychosis on Physical Activity: A Pilot Randomised Controlled Trial
Verified date | June 2024 |
Source | Chinese University of Hong Kong |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This pilot randomized controlled trial aims to determine the feasibility, acceptability and preliminary effects of an Acceptance and Commitment Therapy-based Lifestyle Counselling Programme (ACT-LCP) on the physical and psychosocial health outcomes of patients with early psychosis over a 12-week follow-up.
Status | Completed |
Enrollment | 72 |
Est. completion date | February 28, 2024 |
Est. primary completion date | August 31, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion criteria: 1. at least 18 years of age or above 2. able to understand the nature of the study and give informed consent, 3. able to communicate in Cantonese, 4. have a diagnosis of psychotic disorders (e.g., delusional/brief psychotic disorder, schizotypal disorder, and psychosis not otherwise specified) according to the DSM IV-TR, DSM-V or ICD-10, within 5 years of onset as documented in their clinical/written records; 5. insufficiently active (i.e., <150 minutes of MVPA per week) based on self-reports in a brief screening form, and 6. having used mobile instant-messaging apps (e.g. WhatsApp/Facebook messenger/WeChat) installed on a smartphone. Exclusion criteria: 1. have had a record of alcohol abuse and/or substance misuse, 2. poor physical health condition, acute/severe medical diseases seriously reducing their life expectancy or ability to participate, 3. pregnancy or within six months of postpartum, 4. have received (within the past 6 months) or are receiving other physical and psychosocial interventions, and 5. severe psychiatric symptoms appeared in the past month. |
Country | Name | City | State |
---|---|---|---|
Hong Kong | Department of Psychiatry, North District Hospital | Sheung Shui | New Territories |
Lead Sponsor | Collaborator |
---|---|
Chinese University of Hong Kong | North District Hospital |
Hong Kong,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Physical activity | An accelerometer-based wristband activity tracker, the Fitbit Inspire 2, will be used to measure the total number of minutes spent on moderate to vigorous physical activity (MVPA). Examples of MVPA include brisk walking, climbing stairs, dancing or doing household chores (moderate activity), running, fast cycling, fast swimming, or playing sport (vigorous activity).The data are considered valid if the participants wear the Fitbit for =10 hours/day on =5 consecutive days (4 valid weekdays+1 valid weekend day). Higher minutes indicate more physically active. | Change from baseline assessment to 12 weeks post-intervention | |
Secondary | Healthy dietary intake | The 8-item Starting-The-Conversation is a simplified food frequency instrument for identifying healthy and unhealthy dietary behaviours. Item scores are added to create a summary score (minimum score: 0; maximum score: 6), with higher summary scores reflecting the greatest room for improvement. The STC had acceptable construct validity and was found sensitive to change (Paxton et al., 2011) | Change from baseline assessment to 12 weeks post-intervention | |
Secondary | Autonomous motivation | The 19-item Chinese version of the Behavioural Regulation in Exercise Questionnaire-2 will be used to measure why the participants engage in physical activity by providing several possible reasons that represent varying degrees of motivation (19 items, 5-point Likert Scale). Item scores are added to create a summary score (minimum score: 0; maximum score: 76), with higher summary scores reflecting the greatest room for improvement. This instrument had adequate internal consistencies (a=.75), factorial validity and discriminant validity in Hong Kong university students (Chung et al. 2012). | Change from baseline assessment to 12 weeks post-intervention | |
Secondary | Psychological flexibility | The 7-item Chinese version of the Acceptance and Action Questionnaire-II. The scale of 1 (never true) to 7 (always true). Item scores are added to create a summary score (minimum score: 7; maximum score: 49), with higher summary scores indicating poor psychological flexibility (i.e., more psychologically inflexible) and a lower total score reflect high psychological flexibility. It demonstrated good internal consistencies (a = .88) and test-retest reliabilities (r = .79-.81) in adult populations in Hong Kong (Chong et al., 2019). | Change from baseline assessment to 12 weeks post-intervention | |
Secondary | Mental status | The 18-item Chinese version of the Brief Psychiatric Rating Scale will be used to assess the mental status of the participants. Items are rated on a 7-point Likert scale, from 1 = "not present" to 7 = "extremely severe". Items scores are added to create a summary score (minimum score: 18; maximum score: 126), with higher scores indicate poor mental health. This scale has been used globally in mental health services research, with previous studies indicating good content validity and internal consistency (a = .88) in people with mental illness in Hong Kong (Chien et al., 2015). A higher score suggests a greater level of psychopathology.
. |
Change from baseline assessment to 12 weeks post-intervention | |
Secondary | Perceived quality of life | The 26-item Chinese version of the World Health Organization Quality of Life-BREF will be adopted to assess the quality of life as perceived by patients, in terms of physical health, psychological health, social relationship and environmental quality of life. Responses to questions are on a 1-5 Likert scale where 1 represents "disagree" or "not at all" and 5 represents "completely agree" or "extremely". Items scores are added to create a summary score (minimum score: 26; maximum score: 130), with higher scores indicate stronger perceptions along with that question item. This instrument was modified from the World Health Organization Quality of Life-100, it has been shown to have satisfactory internal consistency and test-retest reliability among Chinese psychiatric patients (Leung et al., 1997). | Change from baseline assessment to 12 weeks post-intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Enrolling by invitation |
NCT03090490 -
10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
|
N/A | |
Completed |
NCT03323437 -
Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia
|
Phase 4 | |
Recruiting |
NCT06423651 -
Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders
|
N/A | |
Completed |
NCT06040944 -
Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
|
||
Recruiting |
NCT04452175 -
Cigarette Consumption After switchinG to High or Low Nicotine strENght E-cigaretteS In Smokers With Schizophrenia
|
N/A | |
Completed |
NCT03501888 -
Cognitive Behavior Therapy for Patients With Psychoses.
|
N/A | |
Completed |
NCT05601063 -
Ascertaining Diagnosis Classification With Elicited Speech
|
||
Recruiting |
NCT05877716 -
EPI-MINN: Targeting Cognition and Motivation - National
|
N/A | |
Completed |
NCT03955549 -
Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-Armed Comparative Randomized Controlled Trial
|
Phase 3 | |
Completed |
NCT03235908 -
Copeptin in Outcome Prediction of an Acute Psychotic Episode
|
||
Recruiting |
NCT05622201 -
A Randomized Controlled Trial With Rituximab for Psychotic Disorder in Adults
|
Phase 2 | |
Recruiting |
NCT05491486 -
Mindfulness, Empathy and the Oxytocinergic System in Persons With Schizophrenia
|
N/A | |
Recruiting |
NCT04104347 -
Metacognitive Training and Insight in Schizophrenia
|
N/A | |
Recruiting |
NCT05664594 -
State Representation in Early Psychosis - Project 4
|
N/A | |
Recruiting |
NCT05538832 -
Remote State Representation in Early Psychosis
|
Early Phase 1 | |
Completed |
NCT02220504 -
3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
|
N/A | |
Completed |
NCT04665401 -
Personalizing Interventions Using Real-World Interactions
|
N/A | |
Recruiting |
NCT03919760 -
Early Psychosis Intervention - Spreading Evidence-based Treatment
|